Video

Dr. Savvides on the Risk of COVID-19 in Patients With Cancer

Panayiotis S. Savvides, MD, discusses COVID-19 precautions for patients with lung cancer.

Panayiotis S. Savvides, MD, a medical oncologist at Mayo Clinic Arizona, discusses COVID-19 precautions for patients with lung cancer.

The situation with COVID-19 continues to rapidly evolve, with providers working hard to observe all available information and rapidly communicate with one another as they try to extrapolate the data from epidemiologic observations, says Savvides. It appears that those who are more susceptible to experiencing severe, and potentially lethal, complications from COVID-19 infection have certain characteristics. Susceptible populations include those who are elderly, those with significant comorbidities, and those who are immunosuppressed. Many patients with lung cancer are included in the latter category, says Savvides. As a group, all patients with cancer who are undergoing active treatment and are immunosuppressed have to be more careful and physicians must try to minimize their exposure to the virus, concludes Savvides.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD